Literature DB >> 29799111

Decreasing Use of Percutaneous Endoscopic Gastrostomy Tube Feeding in Japan.

Kosaku Komiya1,2, Yuko Usagawa1, Jun-Ichi Kadota1, Naoki Ikegami2.   

Abstract

OBJECTIVES: To identify trends in percutaneous endoscopic gastrostomy (PEG) tube placement and intravenous hyperalimentation (IVH) in nonhospital settings (as a potential alternative to tube feeding for nutrition) and to summarize published reports concerning the decision-making process for PEG placement.
DESIGN: National survey and systematic review.
SETTING: Japan. PARTICIPANTS: All Japanese people. MEASUREMENTS: Data on numbers of individuals with a PEG tube and IVH were obtained from the website of the Japanese Ministry of Health, Labour, and Welfare and published reports concerning the decision-making process for PEG placement in Japan were summarized.
RESULTS: The number of PEG tube placements peaked in 2007 and has been decreasing since Japan experienced the Great East Japan Earthquake in 2011. A further decline was seen in 2015 after the Japanese Ministry of Health, Labour and Welfare revised the fee schedule in 2014. More than half of individuals who had tubes were aged 80 and older during the years observed. In contrast, the number of individuals receiving IVH was lowest in the same year as PEG tube placement peaked and has been increasing ever since. Four studies reported that the decision-making process included consideration of not only the underlying disease, but also the individual's age and social barriers and the physician's personal philosophy.
CONCLUSION: The number of PEG tube placements has been decreasing since its peak in 2007, and the number of individuals receiving IVH has been increasing. Many factors influence the decision-making process for PEG tube placement. Physicians in Japan may be realizing that there is little evidence to support the use of tube feeding in frail elderly adults.
© 2018, Copyright the Authors Journal compilation © 2018, The American Geriatrics Society.

Entities:  

Keywords:  intravenous hyperalimentation; percutaneous endoscopic gastrostomy; tube feeding

Mesh:

Year:  2018        PMID: 29799111     DOI: 10.1111/jgs.15386

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  5 in total

1.  Prevalence and Trends in Percutaneous Endoscopic Gastrostomy Placement: Results From a 10-Year, Nationwide Analysis.

Authors:  Marcin Folwarski; Stanislaw Klek; Michał Brzeziński; Agnieszka Szlagatys-Sidorkiewicz; Adam Wyszomirski; Jarosław Meyer-Szary; Karolina Skonieczna-Żydecka
Journal:  Front Nutr       Date:  2022-05-30

2.  Comparison of long-term outcomes between enteral nutrition via gastrostomy and total parenteral nutrition in older persons with dysphagia: A propensity-matched cohort study.

Authors:  Shigenori Masaki; Takashi Kawamoto
Journal:  PLoS One       Date:  2019-10-02       Impact factor: 3.240

3.  Pseudovolvulus of the sigmoid colon after percutaneous endoscopic gastrostomy tube placement: A case report.

Authors:  Motohiro Kikuawa; Akira Kuriyama; Hayaki Uchino
Journal:  Int J Surg Case Rep       Date:  2020-02-28

4.  Long-term prognosis of enteral feeding and parenteral nutrition in a population aged 75 years and older: a population-based cohort study.

Authors:  Yukio Tsugihashi; Manabu Akahane; Yasuhiro Nakanishi; Tomoya Myojin; Shinichiro Kubo; Yuichi Nishioka; Tatsuya Noda; Shuichiro Hayashi; Shiori Furihata; Tsuneyuki Higashino; Tomoaki Imamura
Journal:  BMC Geriatr       Date:  2021-01-28       Impact factor: 3.921

5.  Older adults' preferences for and actual situations of artificial hydration and nutrition in end-of-life care: An 11-year follow-up study in a care home.

Authors:  Taizo Wada; Yasuko Ishimoto; Kiichi Hirayama; Emiko Kato; Mai Tatsuno; Michiko Fujisawa; Yumi Kimura; Yoriko Kasahara; Eriko Fukutomi; Hissei Imai; Masahiro Nakatsuka; Mitsuhiro Nose; Masanori Iwasaki; Satoko Kakuta; Mayumi Hirosaki; Kiyohito Okumiya; Kozo Matsubayashi; Ryota Sakamoto
Journal:  Geriatr Gerontol Int       Date:  2022-06-18       Impact factor: 3.387

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.